Science journalist
Elie Dolgin, PhD, is a freelance science journalist who specializes in biomedical research and drug discovery.
Elie Dolgin is a science journalist who splits his time between rural Vermont and urban Massachusetts. He holds a bachelor's degree in biology from McGill University and a PhD in evolutionary genetics from the University of Edinburgh. A former news editor at STAT, Nature Medicine and The Scientist, Elie has also written for publications including the New York Times, Newsweek and Science magazine.
His 2021 feature article for Nature, "The tangled history of mRNA vaccines," gained significant recognition and was referenced widely in the scientific literature, in national newspaper stories and by award selection committees.
In The Media
Recent Projects
Zebras and giraffes offer one another protection without food competition.
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with fewer side effects.
A new tool predicts where proteins fit, opening new frontiers in drug discovery.
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
How a tissue-swelling method brought super-resolution imaging to the masses.
In response to cellular stress, proteins become ensnared in chemical traffic jams, creating a kind of widespread sluggishness scientists call “proteolethargy.”
The first example of fiber optics in nature could light the way for internet innovation.
Pulses of light and sound seem to have beneficial effects. But some argue it is too soon to market experimental devices.
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.